12 Health Care Stocks Moving In Monday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Monday's intraday session, several health care stocks experienced significant movements. Akili, ZyVersa Therapeutics, Ocean Biomedical, Krystal Biotech, Milestone Pharmaceuticals, and Butterfly Network were among the gainers, with Akili leading at a 121.1% increase. On the downside, Aclarion, Venus Concept, ThermoGenesis Holdings, Bone Biologics, NGM Biopharmaceuticals, and Concord Medical Services saw notable declines, with Aclarion dropping 63%. Market capitalizations varied widely among these companies, reflecting their diverse sizes and impacts within the health care sector.
February 26, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Akili's stock rose 121.1% to $0.49, with a market cap of $38.3 million.
The significant rise in Akili's stock price indicates strong investor interest, potentially due to positive developments or expectations, leading to a likely short-term upward momentum.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Butterfly Network's shares moved upwards by 36.27% to $1.39, with a market cap of $287.9 million.
Butterfly Network's significant stock price increase suggests investor optimism, potentially leading to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Krystal Biotech's stock increased by 39.37% to $155.16, with a market cap of $4.3 billion. The company released its Q4 earnings.
Krystal Biotech's stock price surge following its Q4 earnings release suggests the market positively received the financial results, indicating potential for continued short-term growth.
CONFIDENCE 95
IMPORTANCE 95
RELEVANCE 100
POSITIVE IMPACT
Milestone Pharmaceuticals' shares increased by 38.23% to $2.35, with a market cap of $78.6 million.
The notable rise in Milestone Pharmaceuticals' stock price could reflect positive investor sentiment, likely contributing to short-term upward price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Ocean Biomedical's stock rose 66.24% to $2.61, with a market cap of $88.9 million.
The significant increase in Ocean Biomedical's stock price could indicate strong investor confidence, suggesting a positive short-term outlook.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
ZyVersa Therapeutics' stock increased by 69.78% to $1.36, with a market cap of $6.2 million.
ZyVersa Therapeutics' substantial stock price increase suggests positive market reception, likely driving further short-term gains.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100